Hans - Peter Rudolf

Hans Peter Rudolf is currently working as the Chief Financial Officer at ReLive Biotechnologies Limited. Prior to this, Hans Peter held the same position at Shield Therapeutics plc and Vicarius Pharma. Before venturing into the pharmaceutical industry, Hans Peter served as the Head of Group Accounting and Reporting at Cofra Holding AG and gained significant experience as an Audit Partner at Crowe Horwath LLP, Ernst & Young, and Deloitte. Hans holds a Bachelor's degree in Accounting from Cleveland State University, a Vordiplom in Wirtschaftswissenschaften from the University of Zurich, and a Matura Typ C from Kantonsschule Zug.